Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVipera Regulatory News (VIP)

Share Price Information for Vipera (VIP)

Share Price is delayed by 15 minutes
Get Live Data
201.50    7.50 (3.87%)
Bid:
194.00
Ask:
209.00
Spread: 15.00 (7.732%)
Market Cap: £82.54m
VIP Live PriceLast checked at - London Stock Exchange

Intraday Vipera Share Chart

Fixed Rate Borrowings and Property Purchase

15 May 2026 07:00

RNS Number : 4226E
Value and Indexed Prop Inc Tst PLC
15 May 2026
 

VALUE AND INDEXED PROPERTY INCOME TRUST PLC

 

FIXED RATE BORROWINGS AND PROPERTY PURCHASE

 

BORROWINGS

 

Value and Indexed Property Income Trust PLC (VIP) is pleased to announce the conversion of its undrawn £15 million Revolving Credit Facility, arranged in August 2025, to a Fixed Term Loan maturing on 31 March 2033. The loan was drawn down in full on 7 May 2026 at a fixed interest rate of 5.9% (1.3% above 7-year gilts) and will be used to fund new acquisitions. This brings VIP's average interest rate on all borrowings to 4.9% (of which 96% is at a fixed rate expiring in 2033). The loan to value ratio is 36%. 

 

NEW PURCHASE

 

Following the receipt of £5.44 million from the sale of 2,554,000 shares from Treasury in April 2026 at 213p, at a premium to the Company's latest published Net Asset Value per Share, VIP has bought a freehold cinema in the affluent commuter town of Esher in Surrey for £4.6 million, at a net initial yield of 9.0%, rising to an estimated 9.3% in July this year. This four screen cinema is let to Everyman Media Group Plc for a further 19.2 years, with annual RPI-linked rent reviews, subject to a collar and cap of 1% and 5%. 

 

Following completion of the purchase on 2 June, the portfolio's net initial yield will remain at 6.8% and the portfolio's WAULT (Weighted Average Unexpired Lease Term) will increase to 13.9 years to break from 13.6 years and 16.0 years to expiry from 15.8 years. 

 

Further information can be found here:

https://www.olimproperty.co.uk/value-and-indexed-property-income-trust.html

 

Enquiries:

OLIM Property Limited, Investment Manager

Tel: 020 7846 3252

Sarah.martin@olimproperty.co.uk

Matthew.oakeshott@olimproperty.co.uk

Louise.cleary@olimproperty.co.uk

 

Maven Capital Partners UK LLP

Company Secretary

Tel: 0141 306 7400

 

15 May 2026

 

Important information

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the UK version of the Market Abuse Regulations (EU) No. 596/2014, which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended. Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUSUNRNWUVAAR
Date   Source Headline
15th May 20267:00 amRNSFixed Rate Borrowings and Property Purchase
20th Apr 20267:00 amRNSIssue of Shares from Treasury
10th Apr 20263:58 pmRNSInvestor Meet Presentation
1st Apr 20264:59 pmRNSHolding(s) in Company
1st Apr 20264:15 pmRNSIssue of Shares from Treasury
1st Apr 20267:05 amRNSStatement re MAR
1st Apr 20267:00 amRNSPortfolio Update and Year End Portfolio Valuation
19th Mar 20264:39 pmRNSTransaction in Own Shares
18th Mar 20264:59 pmRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSDividend Declaration
5th Jan 20267:00 amRNSPortfolio Update and 31 December 2025 Valuation
5th Dec 202512:27 pmRNSDirector/PDMR Shareholding
5th Dec 202512:25 pmRNSHolding(s) in Company
5th Dec 202512:25 pmRNSHolding(s) in Company
24th Nov 20255:00 pmRNSHolding(s) in Company
24th Nov 202511:39 amRNSDividend Declaration
19th Nov 20257:00 amRNSTransaction in Own Shares - Replacement
18th Nov 20255:18 pmRNSTransaction in Own Shares
18th Nov 20253:19 pmRNSInvestor Presentation
17th Nov 20257:00 amRNSHalf-year Financial Report
9th Oct 20257:00 amRNSPortfolio Update, Valuation, Borrowings and Tender
29th Sep 20257:00 amRNSResult of Tender Offer
25th Sep 20254:30 pmRNSResults of General Meeting
2nd Sep 20257:28 amRNSDividend Declaration
2nd Sep 20257:00 amRNSCirc re. Tender Offer
1st Aug 20253:34 pmRNSTender Offer
1st Aug 20253:30 pmRNSStatement re Financial Adviser & Corporate Broker
10th Jul 20253:25 pmRNSResult of AGM
11th Jun 20257:00 amRNSAnnual Financial Report
2nd Apr 20258:05 amRNSTrading Statement
1st Apr 20251:24 pmRNSStatement re tax status
31st Mar 20257:00 amRNSTransaction in Own Shares
21st Mar 20255:01 pmRNSTransaction in Own Shares
20th Mar 20251:59 pmRNSDeclaration of Third Quarterly Dividend
20th Mar 20251:48 pmRNSResult of General Meeting
19th Mar 20255:19 pmRNSTransaction in Own Shares
13th Mar 20255:07 pmRNSTransaction in Own Shares
3rd Mar 20255:06 pmRNSTransaction in Own Shares
27th Feb 20255:05 pmRNSTransaction in Own Shares
25th Feb 202512:31 pmRNSPublication of Circular
24th Feb 20255:17 pmRNSTransaction in Own Shares
21st Feb 20254:51 pmRNSTransaction in Own Shares
20th Feb 20254:55 pmRNSTransaction in Own Shares
19th Feb 20255:05 pmRNSTransaction in Own Shares
14th Feb 20255:32 pmRNSTransaction in Own Shares
28th Jan 20254:54 pmRNSTransaction in Own Shares
27th Jan 20254:58 pmRNSTransaction in Own Shares
21st Jan 20255:13 pmRNSTransaction in Own Shares
9th Jan 20257:00 amRNSTransaction in Own Shares
7th Jan 20255:07 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.